ArticlePloS one2015

Low RBM3 protein expression correlates with clinical stage, prognostic classification and increased risk of treatment failure in testicular non-seminomatous germ cell cancer.

Sven-Erik Olofsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.